You are here: Industry Insights > COVID-19

News List

Gilead seeks marketing authorisation from CDSCO for remdesivir expresspharma
June 01, 2020
The medicine has been issued EUA by the US FDA to treat hospitalised coronavirus patients.
DBT establishes four COVID-19 bio banks expresspharma
June 01, 2020
Oropharyngeal/nasopharyngeal swabs, bronchoalveolar lavage, sputum, blood, urine and stool of COVID19 patients will be collected and archived at these biobanks for future use to develop validated diagnostics, therapeutics, vaccines etc.
Researchers decode neurological symptoms of coronavirus infection expresspharma
June 01, 2020
The scientists said further studies involving brain scans and testing of CNS tissue will be crucial to understanding the biological process of the disease in the nervous system.
PureTech advances experimental COVID-19 drug into global trials pharmatimes
May 29, 2020
UK clinical-stage biotherapeutics group PureTech has unveiled plans to advance its wholly-owned clinical-stage product candidate LYT-100 (deupirfenidone) as a potential treatment for serious respiratory complications ...
Almac Receives Grant to Support COVID-19 Studies contractpharma
May 29, 2020
Almac Clinical Services to provide clinical trial services from protocol through to patient delivery, and Almac Sciences will provide analytical support.
Roche Initiates Phase III Trial in COVID-19 Pneumonia contractpharma
May 29, 2020
To evaluate Actemra/RoActemra plus remdesivir in hospitalized patients with severe Pneumonia.
Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax contractpharma
May 29, 2020
The first 4,000 doses have been delivered for use in the Phase II/III clinical trial COV002 by the University of Oxford.
AveXis Enters Mfg. Pact for Novel Genetic COVID-19 Vax contractpharma
May 29, 2020
AAVCOVID, being developed by U.S. researchers in Massachusetts, leverages adeno-associated viral vector technology to produce immunity.
Experimental stem cell therapy trial for COVID-19 initiated europeanpharmaceuticalreview
May 29, 2020
Researchers announce the first patient has been dosed in a trial testing remestemcel-L, a stem cell therapy, in severe COVID-19 patients on ventilators.
Israeli scientists say Gaucher’s disease drugs may help treat Covid-19 pharmaceutical-technology
May 29, 2020
Scientists from the Israeli Institute for Biological Research (IIBR) claim that analogues of two drugs used for the treatment of Gaucher’s disease could be effective against Covid-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page